CAS: 210108-89-7 - (2R,3R,3aS,4R,6S,7S,8S,10E,12S,13S,13aR)-2,4,6,13-Tetrakis(acetyloxy)-3-(benzoyloxy)-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-1H-cyclopentacyclododecen-8-yl 3-pyridinecarboxylate
Formel:C41H49NO14
InChl:InChI=1S/C41H49NO14/c1-22-17-18-39(7,8)36(55-38(49)29-16-13-19-42-20-29)31(47)33(52-25(4)44)23(2)32(51-24(3)43)30-35(54-37(48)28-14-11-10-12-15-28)40(9,56-27(6)46)21-41(30,50)34(22)53-26(5)45/h10-20,22,30-36,47,50H,2,21H2,1,3-9H3/b18-17+/t22-,30-,31+,32-,33-,34-,35+,36+,40+,41+/m0/s1
InChI Key:InChIKey=GLYDSECXZWCLMS-RWMROPJHSA-N
SMILES:O=C(OC1C(O)C(OC(=O)C)C(=C)C(OC(=O)C)C2C(OC(=O)C=3C=CC=CC3)C(OC(=O)C)(C)CC2(O)C(OC(=O)C)C(C=CC1(C)C)C)C=4C=NC=CC4
3-Pyridinecarboxylic acid, (2R,3R,3aS,4R,6S,7S,8S,10E,12S,13S,13aR)-2,4,6,13-tetrakis(acetyloxy)-3-(benzoyloxy)-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-1H-cyclopentacyclododecen-8-yl ester
Ref: AN-AG002KL4
5mg | Nachfragen |
Jatrophane 5
Ref: TM-TN2726
5mg | Nachfragen | |
1ml*10 (DMSO) | Nachfragen |
2,5,7,14-Tetraacetoxy-3-benzoyloxy-8,15-dihydroxy-9-nicotinoyloxyjatropha-6(17),11E-diene
Ref: 3D-KIA10889
1mg | Nachfragen | |
5mg | Nachfragen | |
10mg | Nachfragen | |
25mg | Nachfragen | |
50mg | Nachfragen |